BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26750249)

  • 1. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
    Wiemann J; Heller L; Csuk R
    Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betulinic acid derived hydroxamates and betulin derived carbamates are interesting scaffolds for the synthesis of novel cytotoxic compounds.
    Wiemann J; Heller L; Perl V; Kluge R; Ströhl D; Csuk R
    Eur J Med Chem; 2015 Dec; 106():194-210. PubMed ID: 26547057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
    Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
    Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical and biological potential of C ring modified triterpenoids.
    Siewert B; Wiemann J; Köwitsch A; Csuk R
    Eur J Med Chem; 2014 Jan; 72():84-101. PubMed ID: 24361521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urea derivates of ursolic, oleanolic and maslinic acid induce apoptosis and are selective cytotoxic for several human tumor cell lines.
    Sommerwerk S; Heller L; Kuhfs J; Csuk R
    Eur J Med Chem; 2016 Aug; 119():1-16. PubMed ID: 27149037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives.
    Liu Q; Liu H; Zhang L; Guo T; Wang P; Geng M; Li Y
    Eur J Med Chem; 2013 Jun; 64():1-15. PubMed ID: 23639650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hederagenin as a triterpene template for the development of new antitumor compounds.
    Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Csuk R; Heller L
    Eur J Med Chem; 2015 Nov; 105():57-62. PubMed ID: 26476750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
    Heller L; Schwarz S; Perl V; Köwitsch A; Siewert B; Csuk R
    Eur J Med Chem; 2015 Aug; 101():391-9. PubMed ID: 26177446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and proapoptotic activity of oleanolic acid derived amides.
    Heller L; Knorrscheidt A; Flemming F; Wiemann J; Sommerwerk S; Pavel IZ; Al-Harrasi A; Csuk R
    Bioorg Chem; 2016 Oct; 68():137-51. PubMed ID: 27518757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of ursolic and oleanolic acids' antitumor activity by complexation with hydrophilic cyclodextrins.
    Oprean C; Mioc M; Csányi E; Ambrus R; Bojin F; Tatu C; Cristea M; Ivan A; Danciu C; Dehelean C; Paunescu V; Soica C
    Biomed Pharmacother; 2016 Oct; 83():1095-1104. PubMed ID: 27551755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing anticancer activity through the combination of bioreducing agents and triterpenes.
    Bednarczyk-Cwynar B; Ruszkowski P; Jarosz T; Krukiewicz K
    Future Med Chem; 2018 Mar; 10(5):511-525. PubMed ID: 29424550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.
    Wolfram RK; Fischer L; Kluge R; Ströhl D; Al-Harrasi A; Csuk R
    Eur J Med Chem; 2018 Jul; 155():869-879. PubMed ID: 29960206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
    Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
    Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase library synthesis of bi-functional derivatives of oleanolic and maslinic acids and their cytotoxicity on three cancer cell lines.
    Parra A; Martin-Fonseca S; Rivas F; Reyes-Zurita FJ; Medina-O'Donnell M; Rufino-Palomares EE; Martinez A; Garcia-Granados A; Lupiañez JA; Albericio F
    ACS Comb Sci; 2014 Aug; 16(8):428-47. PubMed ID: 24916186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis.
    Wolfram RK; Heller L; Csuk R
    Eur J Med Chem; 2018 May; 152():21-30. PubMed ID: 29684707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hederagenin amide derivatives as potential antiproliferative agents.
    Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Ataide Martins JP; Fischer Nee Heller L; Csuk R
    Eur J Med Chem; 2019 Apr; 168():436-446. PubMed ID: 30840925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
    Brandes B; Hoenke S; Fischer L; Csuk R
    Eur J Med Chem; 2020 Jan; 185():111858. PubMed ID: 31718946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
    Hao J; Liu J; Wen X; Sun H
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platanic acid: A new scaffold for the synthesis of cytotoxic agents.
    Kahnt M; Heller L; Grabandt P; Al-Harrasi A; Csuk R
    Eur J Med Chem; 2018 Jan; 143():259-265. PubMed ID: 29197730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethylenediamine Derived Carboxamides of Betulinic and Ursolic Acid as Potential Cytotoxic Agents.
    Kahnt M; Fischer Née Heller L; Al-Harrasi A; Csuk R
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30297604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.